Please assess the completion status of the following clinical trial:

Trial Title: Prevention of Delirium After Bone Marrow Transplantation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 18 or older~* Male or female~* Patients scheduled to undergo HSCT~* English speaking~Exclusion Criteria:~* Previous history of bipolar affective disorder~* On-going delirium~* History of substance abuse/dependence within 6 months prior to HSCT~* History of invasive melanoma. Patients with a history of basal cell carcinoma, melanoma in situ, or squamous cell carcinoma are permitted to enroll if the lesion(s) have been excised with negative margins~* History of medical/dermatological conditions that make skin especially sensitive to light,such as systemic lupus erythematosus (SLE) and/or porphyria~* Eye condition that makes eyes vulnerable to light damage~* Concomitant use of medications that increase sensitivity to sunlight, such as the herbal supplement St. John's Wort~* Established primary insomnia

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Bright light therapy (Type: EXPERIMENTAL): 2500 Lux gaze directed every morning from 8 am until 8:30 am
- Sham light (Type: PLACEBO_COMPARATOR): \<1000 Lux gaze directed every morning from 8 am until 8:30 am

Based on this trial design, predict the completion outcome and termination type (if applicable).